Effects of A3309, an ileal bile acid transporter inhibitor, on colonic transit and symptoms in females with functional constipation

Functional Bowel Disorders

Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856 · see citing works

Stool form scale as a useful guide to intestinal transit time

Lewis, S. J., & Heaton, K. W. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011203 · Cited by 3,244 · see citing works

Functional bowel disorders and functional abdominal pain

Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440 · see citing works

TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis

Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.001 · Cited by 1,885 · see citing works

Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1

Katsuma, S., Hirasawa, A., & Tsujimoto, G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.139 · Cited by 789 · see citing works

Colonic Secretion of Water and Electrolytes Induced by Bile Acids: Perfusion Studies in Man

Mekhjian, H. S., Phillips, S. F., & Hofmann, A. F. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106644 · Cited by 584 · see citing works

Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation

Raimondi, F., Santoro, P., Barone, M. V., Pappacoda, S., Barretta, M. L., Nanayakkara, M., Apicella, C., Capasso, L., & Paludetto, R. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00043.2007 · Cited by 286 · see citing works

Effect of molecular structure on bile acid-induced alterations in absorptive function, permeability, and morphology in the perfused rabbit colon.

CHADWICK, V. S., Gaginella, T. S., Carlson, G. L., Debongnie, J. C., Phillips, S. F., & Hofmann, A. F. (1979) · PubMed · Cited by 271 · see citing works

Effect of 5 Days Linaclotide on Transit and Bowel Function in Females With Constipation-Predominant Irritable Bowel Syndrome

Andresen, V., Camilleri, M., Busciglio, I. A., Grudell, A., Burton, D. D., McKinzie, S., Foxx–Orenstein, A. E., Kurtz, C. B., Sharma, V., Johnston, J. M., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.067 · Cited by 245 · see citing works

Prospective Study of Motor, Sensory, Psychologic, and Autonomic Functions in Patients With Irritable Bowel Syndrome

Camilleri, M., McKinzie, S., Busciglio, I. A., Low, P. A., Sweetser, S. R., Burton, D. D., Baxter, K. L., Ryks, M. D., & Zinsmeister, A. R. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.060 · Cited by 242 · see citing works

The proximal colonic motor response to rectal mechanical and chemical stimulation

Bampton, P. A., Dinning, P. G., Kennedy, M. L., Lubowski, D. Z., & Cook, I. J. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00194.2001 · Cited by 215 · see citing works

Inability of the Rome III Criteria to Distinguish Functional Constipation From Constipation-Subtype Irritable Bowel Syndrome

Wong, R. K., Palsson, O. S., Turner, M. J., Levy, R. L., Feld, A. D., von Korff, M., & Whitehead, W. E. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.200 · Cited by 204 · see citing works

Monitoring hepatic cholesterol 7α-hydroxylase activity by assay of the stable bile acid intermediate 7α-hydroxy-4-cholesten-3-one in peripheral blood

Gälman, C., Arvidsson, I., Angelin, B., & Rudling, M. (2003) · Journal of Lipid Research · doi:10.1194/jlr.d200043-jlr200 · Cited by 194 · see citing works

Performance characteristics of scintigraphic transit measurements for studies of experimental therapies

Cremonini, F., Mullan, B. P., Camilleri, M., Burton, D. D., & Rank, M. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01344.x · Cited by 183 · see citing works

Chenodeoxycholate in Females With Irritable Bowel Syndrome-Constipation: A Pharmacodynamic and Pharmacogenetic Analysis

Rao, A. S., Wong, B. S., Camilleri, M., Odunsi, S. T., McKinzie, S., Ryks, M. D., Burton, D. D., Carlson, P., Lamsam, J. L., Singh, R. J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.052 · Cited by 182 · see citing works

Effects of Chenodeoxycholate and a Bile Acid Sequestrant, Colesevelam, on Intestinal Transit and Bowel Function

Odunsi, S. T., Camilleri, M., McKinzie, S., Burton, D. D., Carlson, P., Busciglio, I. A., Lamsam, J. L., Singh, R. J., & Zinsmeister, A. R. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.10.020 · Cited by 182 · see citing works

A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation

Chey, W. D., Camilleri, M., Chang, L., Rikner, L., & Graffner, H. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.162 · Cited by 176 · see citing works

Bile acids and colonic motility in the rabbit and the human.

Kirwan, W. O., Smith, A. N., Mitchell, W. D., Falconer, J. D., & Eastwood, M. A. (1975) · Gut · doi:10.1136/gut.16.11.894 · Cited by 154 · see citing works

Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort

manabe, N., wong, B. S., camilleri, M., burton, D., mckinzie, S., & zinsmeister, A. R. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01442.x · Cited by 142 · see citing works

Bile acids: short and long term effects in the intestine

Bajor, A., Gillberg, P., & Abrahamsson, H. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521003702734 · Cited by 138 · see citing works

EFFECT OF DIFFERENT DOSES OF CHENODEOXYCHOLIC ACID ON BILE-LIPID COMPOSITION AND ON FREQUENCY OF SIDE-EFFECTS IN PATIENTS WITH GALLSTONES

Mok, H. Y. I., Bell, G. D., & Dowling, R. H. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91415-9 · Cited by 131 · see citing works

Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias.

Buchwald, H., Varco, R., Boen, J., Williams, S. E., Hansen, B., Campos, C. T., Campbell, G. S., Pearce, M. B., Yellin, A., Edmiston, W., et al. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.11.1253 · Cited by 121 · see citing works

Bile acid stimulation of colonic adenylate cyclase and secretion in the rabbit

Conley, D. R., Coyne, M. J., Bonorris, G., Chung, A., & Schoenfield, L. J. (1976) · Digestive Diseases and Sciences · doi:10.1007/bf01072128 · Cited by 119 · see citing works

Randomised clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation - a double-blind study: Randomised clinical trial: the ASBT/IBAT inhibitor A3309 in constipation

Simrén, M., Bajor, A., Gillberg, P.-G., Rudling, M., & Abrahamsson, H. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04675.x · Cited by 114 · see citing works

Performance characteristics of scintigraphic colon transit measurement in health and irritable bowel syndrome and relationship to bowel functions

Deiteren, A., Camilleri, M., Bharucha, A. E., Burton, D. D., McKinzie, S., Rao, A. S., & Zinsmeister, A. R. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01441.x · Cited by 111 · see citing works

Serum 7α-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea

Brydon, W. G., Nyhlin, H., Eastwood, M. A., & Merrick, M. V. (1996) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199602000-00005 · Cited by 100 · see citing works

Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C

Rao, G., & Pandya, P. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.055 · Cited by 89 · see citing works

Chenodeoxycholic Acid

Iser, J. H., & Sali, A. (1981) · Drugs · doi:10.2165/00003495-198121020-00002 · Cited by 79 · see citing works

Determination of bile acid pool size in man: a simplified method with advantages of increases precision, shortened analysis time, and decreased isotope exposure

Duane, W. C., Adler, R. D., Bennion, L. J., & Ginsberg, R. L. (1975) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36742-0 · Cited by 79 · see citing works

Overall Mortality, Incremental Life Expectancy, and Cause of Death at 25 Years in the Program on the Surgical Control of the Hyperlipidemias

Buchwald, H., Rudser, K. D., Williams, S. E., Michalek, V. N., Vagasky, J., & Connett, J. E. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181deb4d0 · Cited by 73 · see citing works

Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation

Abrahamsson, H., Östlund-Lindqvist, A.-M., Nilsson, R., Simrén, M., & Gillberg, P.-G. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802321212 · Cited by 67 · see citing works

Dose-related effects of chenodeoxycholic acid in the rabbit colon

Camilleri, M., Murphy, R., & CHADWICK, V. S. (1980) · Digestive Diseases and Sciences · doi:10.1007/bf01395507 · Cited by 65 · see citing works

Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes?

Knop, F. K. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00137.2010 · Cited by 62 · see citing works

Scintigraphic Biomarkers for Colonic Dysmotility

Camilleri, M. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.23 · Cited by 54 · see citing works

Bile acids in the diarrhoea of ileal resection

Mitchell, W. D., Findlay, J. M., Prescott, R. J., Eastwood, M. A., & Horn, D. B. (1973) · Gut · doi:10.1136/gut.14.5.348 · Cited by 53 · see citing works

Taurodeoxycholate modulates apical Cl-/OH- exchange activity in Caco2 cells

Alrefai, W. A., Saksena, S., Tyagi, S., Gill, R. K., Ramaswamy, K., & Dudeja, P. K. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9090-8 · Cited by 51 · see citing works

Effect of change of fecal bile acid excretion achieved by operative procedures on 1,2-dimethylhydrazine-induced colon cancer in rats

Morvay, K., Szentléleki, K., Török, G., Pintér, A., Börzsönyi, M., & Nawroth, R. (1989) · Diseases of the Colon & Rectum · doi:10.1007/bf02554556 · Cited by 45 · see citing works

S1301 The IBAT Inhibition by A3309 – A Potential Mechanism for the Treatment of Constipation

Gillberg, P., Dahlström, M., Starke, I., & Östlund‐Lindqvist, A. (2010) · Gastroenterology · doi:10.1016/s0016-5085(10)61017-7 · Cited by 25 · see citing works

Efficacy and Safety of Once Daily Linaclotide in Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial Followed by a 4-Week Randomized Withdrawal Period

Rao, S. S. C., Lembo, A. J., Shiff, S. J., Shi, K., Johnston, J. M., & Schneier, H. A. (2011) · Gastroenterology · doi:10.1016/s0016-5085(11)60561-1 · Cited by 13 · see citing works

Bowel Disorders

Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866 · see citing works

American Gastroenterological Association Technical Review on Constipation

Bharucha, A. E., Pembérton, J. H., & Locke, G. R. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.10.028 · Cited by 914 · see citing works

Irritable bowel syndrome

Ford, A. C., Sperber, A. D., Corsetti, M., & Camilleri, M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31548-8 · Cited by 818 · see citing works

American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation

Ford, A. C., Moayyedi, P., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E., Spiegel, B. M. R., & Quigley, E. M. M. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.187 · Cited by 648 · see citing works

Management of functional constipation in children and adults

Vriesman, M. H., Koppen, I. J. N., Camilleri, M., Di Lorenzo, C., & Benninga, M. A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0222-y · Cited by 457 · see citing works

Mechanisms of Action of Probiotics and the Gastrointestinal Microbiota on Gut Motility and Constipation

Dimidi, E., Christodoulides, S., Scott, S. M., & Whelan, K. (2017) · Advances in Nutrition · doi:10.3945/an.116.014407 · Cited by 468 · see citing works

Guts and Gall: Bile Acids in Regulation of Intestinal Epithelial Function in Health and Disease

Hegyi, P., Maléth, J., Walters, J. R., Hofmann, A. F., & Keely, S. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00054.2017 · Cited by 269 · see citing works

Increased Bile Acid Biosynthesis Is Associated With Irritable Bowel Syndrome With Diarrhea

Wong, B. S., Camilleri, M., Carlson, P., McKinzie, S., Busciglio, I. A., Bondar, O. P., Dyer, R. B., Lamsam, J. L., & Zinsmeister, A. R. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.05.006 · Cited by 217 · see citing works

Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome

Shin, A., Camilleri, M., Vijayvargiya, P., Busciglio, I., Burton, D., Ryks, M., Rhoten, D., Lueke, A., Saenger, A., Girtman, A., et al. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.04.020 · Cited by 192 · see citing works

Role of gut microbiota in functional constipation

Zhang, S., Wang, R., Li, D., Zhao, L., & Zhu, L. (2021) · Gastroenterology Report · doi:10.1093/gastro/goab035 · Cited by 175 · see citing works

Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial

Nakajima, A., Seki, M., Taniguchi, S., Ohta, A., Gillberg, P.-G., Mattsson, J. P., & Camilleri, M. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30123-7 · Cited by 169 · see citing works

Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: a systematic review and network meta-analysis

Nelson, A. D., Camilleri, M., Chirapongsathorn, S., Vijayvargiya, P., Valentin, N., Shin, A., Erwin, P. J., Wang, Z., & Murad, M. H. (2016) · Gut · doi:10.1136/gutjnl-2016-311835 · Cited by 159 · see citing works

Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis

Luthra, P., Camilleri, M., Burr, N. E., Quigley, E. M. M., Black, C. J., & Ford, A. C. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30246-8 · Cited by 140 · see citing works

The SLC10 Carrier Family

Döring, B., Lütteke, T., Geyer, J., & Petzinger, E. (2012) · Current topics in membranes · doi:10.1016/b978-0-12-394316-3.00004-1 · Cited by 128 · see citing works

Intestinal secretory mechanisms and diarrhea

Keely, S. J., & Barrett, K. E. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00316.2021 · Cited by 100 · see citing works

Solute carriers as drug targets: Current use, clinical trials and prospective

Rask‐Andersen, M., Masuram, S., Fredriksson, R., & Schiöth, H. B. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.07.015 · Cited by 98 · see citing works

Guidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised Edition

Shin, J. E., Jung, H., Lee, T. H., Jo, Y., Lee, H., Song, K. H., Hong, S. N., Lim, H. C., Lee, S. J., Chung, S. S., et al. (2016) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15185 · Cited by 96 · see citing works

Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH

Al-Dury, S., & Marschall, H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00931 · Cited by 96 · see citing works

Elobixibat and its potential role in chronic idiopathic constipation

Acosta, A., & Camilleri, M. (2014) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x14528269 · Cited by 91 · see citing works

Bifidobacterium animalis subsp. lactis HN019 Effects on Gut Health: A Review

Cheng, J., Laitila, A., & Ouwehand, A. C. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.790561 · Cited by 90 · see citing works

Potential of ileal bile acid transporter inhibition as a therapeutic target in Alagille syndrome and progressive familial intrahepatic cholestasis

Kamath, B. M., Stein, P., Houwen, R. H. J., & Verkade, H. J. (2020) · Liver International · doi:10.1111/liv.14553 · Cited by 88 · see citing works

Therapeutic targeting of bile acids

Camilleri, M., & Gores, G. J. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00121.2015 · Cited by 87 · see citing works

Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples

Vijayvargiya, P., Busciglio, I. A., Burton, D. D., Donato, L. J., Lueke, A. J., & Camilleri, M. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.06.039 · Cited by 84 · see citing works

Brain‐Gut Axis

Camilleri, M., & Lorenzo, C. D. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31823d34c3 · Cited by 74 · see citing works

Pharmacological treatment for antipsychotic-related constipation

Every‐Palmer, S., Newton‐Howes, G., & Clarke, M. J. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011128.pub2 · Cited by 66 · see citing works

Emerging Treatment Options in Mild to Moderate Ulcerative Colitis.

Lichtenstein, G. R., Hanauer, S. B., & Sandborn, W. J. (2015) · Europe PMC (PubMed Central) · Cited by 66 · see citing works

The role of bile acids in functional GI disorders

Appleby, R., & Walters, J. R. F. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12370 · Cited by 66 · see citing works

The Farnesoid X Receptor: Good for BAD

Keely, S. J., & Walters, J. R. F. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.08.004 · Cited by 64 · see citing works

Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases

Yang, T., Khan, G. J., Wu, Z., Wang, X., Zhang, L., & Jiang, Z. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.09.007 · Cited by 64 · see citing works

Chronic Constipation: a Review of Current Literature

Sbahi, H., & Cash, B. D. (2015) · Current Gastroenterology Reports · doi:10.1007/s11894-015-0471-z · Cited by 62 · see citing works

Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial

Nakajima, A., Seki, M., & Taniguchi, S. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1383-5 · Cited by 62 · see citing works

Specific inhibition of bile acid transport alters plasma lipids and GLP-1

Rudling, M. J., Camilleri, M., Graffner, H., Holst, J. J., & Rikner, L. (2015) · BMC Cardiovascular Disorders · doi:10.1186/s12872-015-0070-9 · Cited by 60 · see citing works

An Update of Pharmacological Management in Children with Functional Constipation

de Geus, A., Koppen, I. J. N., Flint, R. B., Benninga, M. A., & Tabbers, M. M. (2023) · Pediatric Drugs · doi:10.1007/s40272-023-00563-0 · Cited by 70 · see citing works

New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond

Sinagra, E., Morreale, G., Mohammadian, G., Fusco, G., Guarnotta, V., Tomasello, G., Cappello, F., Rossi, F., Amvrosiadis, G., & Raimondo, D. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i36.6593 · Cited by 52 · see citing works

Actionable biomarkers: the key to resolving disorders of gastrointestinal function

Camilleri, M., & Chedid, V. G. (2020) · Gut · doi:10.1136/gutjnl-2019-320325 · Cited by 55 · see citing works

Modulating bile acid pathways and TGR5 receptors for treating liver and GI diseases

Malhi, H., & Camilleri, M. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.09.008 · Cited by 54 · see citing works

Chronic constipation: Update on management

Hayat, U., Dugum, M. F., & Garg, S. (2017) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.84a.15141 · Cited by 51 · see citing works

Safety, tolerability and pharmacodynamics of apical sodium-dependent bile acid transporter inhibition with volixibat in healthy adults and patients with type 2 diabetes mellitus: a randomised placebo-controlled trial

Tiessen, R. G., Kennedy, C., Keller, B. T., Levin, N., Acevedo, L. M., Gedulin, B. R., van Vliet, A. A., Dorenbaum, A., & Palmer, M. (2018) · BMC Gastroenterology · doi:10.1186/s12876-017-0736-0 · Cited by 50 · see citing works

Elobixibat for the treatment of constipation

Chedid, V. G., Vijayvargiya, P., & Camilleri, M. (2018) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1522248 · Cited by 48 · see citing works

Evidence-Based Clinical Guidelines for Chronic Constipation 2023

Ihara, E., Manabe, N., Ohkubo, H., Ogasawara, N., Ogino, H., Kakimoto, K., Kanazawa, M., Kawahara, H., Kusano, C., Kuribayashi, S., et al. (2024) · Digestion · doi:10.1159/000540912 · Cited by 53 · see citing works

Understanding and treating refractory constipation

Bassotti, G., & Blandizzi, C. (2014) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v5.i2.77 · Cited by 45 · see citing works

Pharmacologic, Pharmacokinetic, and Pharmacogenomic Aspects of Functional Gastrointestinal Disorders

Camilleri, M., Bueno, L. P., Andresen, V., Ponti, F. D., Choi, M., & Lembo, A. J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.029 · Cited by 43 · see citing works

Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles

Zhang, B., Kuipers, F., de Boer, J. F., & Kuivenhoven, J. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm11010004 · Cited by 42 · see citing works

Chronic Idiopathic Constipation in Adults: A Review on Current Guidelines and Emerging Treatment Options

Bassotti, G., Usai–Satta, P., & Bellini, M. (2021) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s256364 · Cited by 39 · see citing works

Elobixibat for the treatment of constipation

Wong, B. S., & Camilleri, M. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.753056 · Cited by 38 · see citing works

Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.

Jadallah, K. A., Kullab, S. M., & Sanders, D. S. (2014) · PubMed Central · doi:10.3748/wjg.v20.i27.8898 · Cited by 37 · see citing works

Chronic constipation: new diagnostic and treatment approaches

Lacy, B. E., Levenick, J. M., & Crowell, M. D. (2012) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x12443093 · Cited by 37 · see citing works

Characteristics of the Gut Microbiome and Serum Metabolome in Patients with Functional Constipation

Wang, J., Wang, L., Yu, Q., Tang, N., Mei, C., Zhang, H., Wang, G., Lu, J., & Chen, W. (2023) · Nutrients · doi:10.3390/nu15071779 · Cited by 36 · see citing works

Open: Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trial

Oduyebo, I., Camilleri, M., Nelson, A. D., Khemani, D., Nord, S. L., Busciglio, I. A., Burton, D. D., Rhoten, D. L., Ryks, M. D., Carlson, P., et al. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0042-7 · Cited by 36 · see citing works

Childhood constipation: finally something is moving!

Koppen, I. J. N., Lorenzo, C. D., Saps, M., Dinning, P. G., Yacob, D., Levitt, M. A., & Benninga, M. A. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1098533 · Cited by 35 · see citing works

Effect of single and multiple doses of elobixibat, an ileal bile acid transporter inhibitor, on chronic constipation: A randomized controlled trial

Kumagai, Y., Amano, H., Sasaki, Y., Nakagawa, C., Maeda, M., Oikawa, I., & Furuie, H. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13698 · Cited by 35 · see citing works

Guidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised Edition

Shin, J. E., Jung, H., Lee, T. H., Jo, Y., Lee, H., Song, K. H., Hong, S. N., Lim, H. C., Lee, S. J., Chung, S. S., et al. (2016) · Korean Journal of Medicine · doi:10.3904/kjm.2016.91.2.114 · Cited by 34 · see citing works

Tegaserod for the Treatment of Irritable Bowel Syndrome

Madia, V. N., Messore, A., Saccoliti, F., Tudino, V., Leo, A. D., Vita, D. D., Bortolami, M., Scipione, L., Pindinello, I., Costi, R., et al. (2019) · Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry · doi:10.2174/1871523018666190911121306 · Cited by 34 · see citing works

Efficacy, long‐term safety, and impact on quality of life of elobixibat in more severe constipation: post hoc analyses of two phase 3 trials in Japan

Nakajima, A., Taniguchi, S., Kurosu, S., Gillberg, P., Mattsson, J. P., & Camilleri, M. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13571 · Cited by 33 · see citing works

Pharmacological agents currently in clinical trials for disorders in neurogastroenterology

Camilleri, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70837 · Cited by 32 · see citing works

Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatments

Müller-Lissner, S. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.773972 · Cited by 31 · see citing works

The Mexican consensus on chronic constipation

Remes-Troche, J. M., Coss‐Adame, E., López‐Colombo, A., Amieva‐Balmori, M., Sánchez, R. C., Guindic, L. C., Rendón, R. F., Escudero, O. G., Martínez, M. G., Chávez, M. E. I., et al. (2018) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2018.05.012 · Cited by 31 · see citing works

Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials

Valentin, N., Acosta, A. J., & Camilleri, M. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1025132 · Cited by 29 · see citing works

Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation

Eswaran, S. L., Guentner, A. S., & Chey, W. D. (2014) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2014.20.2.141 · Cited by 29 · see citing works

Description of analytical method and clinical utility of measuring serum 7-alpha-hydroxy-4-cholesten-3-one (7aC4) by mass spectrometry

Donato, L. J., Lueke, A. J., Kenyon, S. M., Meeusen, J. W., & Camilleri, M. (2017) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2017.10.008 · Cited by 28 · see citing works

Impact of elobixibat on serum and fecal bile acid levels and constipation symptoms in patients with chronic constipation

Nakajima, A., Ishizaki, S., Matsuda, K. M., Kurosu, S., Taniguchi, S., Gillberg, P., Mattsson, J. P., Hasunuma, T., & Camilleri, M. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15800 · Cited by 28 · see citing works

Pharmacodynamic and Clinical Endpoints for Functional Colonic Disorders: Statistical Considerations

Zinsmeister, A. R., Burton, D. D., & Camilleri, M. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2369-z · Cited by 26 · see citing works

Review article: Elobixibat: a novel treatment for chronic constipation

Khanna, L., & Camilleri, M. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16143 · Cited by 24 · see citing works

Current and Emerging Pharmacotherapeutic Options for Irritable Bowel Syndrome

Barboza, J., Talley, N. J., & Moshiree, B. (2014) · Drugs · doi:10.1007/s40265-014-0292-7 · Cited by 24 · see citing works

Review of efficacy and safety of laxatives use in geriatrics

Izzy, M. J., Malieckal, A., Little, E., & Anand, S. (2016) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v7.i2.334 · Cited by 24 · see citing works

Elobixibat, the first-in-class Ileal Bile Acid Transporter inhibitor, for the treatment of Chronic Idiopathic Constipation

Miner, P. B. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1508450 · Cited by 23 · see citing works

Tenapanor hydrochloride for the treatment of constipation-predominant irritable bowel syndrome

Zielińska, M., Wasilewski, A., & Fichna, J. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1054480 · Cited by 22 · see citing works

Elobixibat, an ileal bile acid transporter inhibitor, induces giant migrating contractions during natural defecation in conscious dogs

Taniguchi, S., Yano, T., Imaizumi, M., & Manabe, N. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13448 · Cited by 21 · see citing works

The gut microbiome and metabolites are altered and interrelated in patients with functional constipation

Li, Y.-Q., Yan, X.-Y., Xiao, X.-J., Ma, P.-T., Wang, S.-Q., Liu, H.-L., Zhang, W., Chen, M., Yao, J.-P., & Li, Y. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1320567 · Cited by 22 · see citing works

Phase II drugs under clinical investigation for the treatment of chronic constipation

Mozaffari, S., Didari, T., Nikfar, S., & Abdollahi, M. R. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.932770 · Cited by 20 · see citing works

Bile Acid Diarrhea and NAFLD: Shared Pathways for Distinct Phenotypes

Weaver, M. J., Mchenry, S. A., Sayuk, G. S., Gyawali, C. P., & Davidson, N. O. (2020) · Hepatology Communications · doi:10.1002/hep4.1485 · Cited by 19 · see citing works

Ileal Bile Acid Transporter Inhibition Reduces Post-Transplant Diarrhea and Growth Failure in FIC1 Disease—A Case Report

Ohlendorf, J., Goldschmidt, I., Junge, N., Laue, T., Nasser, H., Jäckel, E., Mutschler, F. E., Pfister, E., Herebian, D. A., Keitel, V., et al. (2022) · Children · doi:10.3390/children9050669 · Cited by 19 · see citing works

Exposure of Ldlr−/− Mice to a PFAS Mixture and Outcomes Related to Circulating Lipids, Bile Acid Excretion, and the Intestinal Transporter ASBT

Roth, K., Yang, Z., Agarwal, M., Birbeck, J. A., Westrick, J. A., Lydic, T. A., Gurdziel, K., & Petriello, M. C. (2024) · Environmental Health Perspectives · doi:10.1289/ehp14339 · Cited by 18 · see citing works

Home‐Based Transcutaneous Neuromodulation Improved Constipation via Modulating Gastrointestinal Hormones and Bile Acids

Ge, Z., Duan, Z., Yang, H., Zhang, S., Zhang, S., Wang, L., Yang, D., Sun, X., Zhang, Z., Su, L., et al. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/2086163 · Cited by 18 · see citing works

Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review

Mosińska, P., Sałaga, M., & Fichna, J. (2016) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2016.1142532 · Cited by 17 · see citing works

Safety and Efficacy of Elobixibat, an Ileal Bile Acid Transporter Inhibitor, in Elderly Patients With Chronic Idiopathic Constipation According to Administration Time: Interim Analysis of Post-marketing Surveillance

Nakajima, A., Fujimaki, M., Arai, Y., & Emori, K. (2022) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm20263 · Cited by 16 · see citing works

Consenso mexicano sobre estreñimiento crónico

Remes-Troche, J. M., Coss‐Adame, E., López‐Colombo, A., Amieva‐Balmori, M., Sánchez, R. C., Guindic, L. C., Rendón, R. F., Escudero, O. G., Martínez, M. G., Chávez, M. E. I., et al. (2018) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2017.12.005 · Cited by 18 · see citing works

Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study

Kamei, D., Kamei, Y., Nagano, M., Mineshima, M., Nitta, K., & Tsuchiya, K. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-1179-6 · Cited by 16 · see citing works

New Options in Constipation Management

Davis, M. P., & Gamier, P. (2015) · Current Oncology Reports · doi:10.1007/s11912-015-0481-x · Cited by 16 · see citing works

New pharmacological treatment options for chronic constipation

Corsetti, M., & Tack, J. F. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.900543 · Cited by 15 · see citing works

Treatment for constipation: New and old pharmacological strategies

Lacy, B. E., Hussain, Z. H., & Mearin, F. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12335 · Cited by 14 · see citing works

Treatment of Chronic Constipation: Prescription Medications and Surgical Therapies.

Hussain, Z. H., Everhart, K. K., & Lacy, B. E. (2015) · PubMed Central · Cited by 14 · see citing works

Potential Targets in Constipation Research: A Review

Ravichandiran, V., Arumugam, S., Bisht, P., Dagar, N., & Kumar, N. (2022) · Current Drug Targets · doi:10.2174/1389450124666221209123541 · Cited by 15 · see citing works

Pharmacotherapeutic advances for chronic idiopathic constipation in adults

Bassotti, G., Usai–Satta, P., Berti, G., Lai, M., Villanacci, V., & Bellini, M. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2150076 · Cited by 13 · see citing works

Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents

Yang, H. Y., & Ma, T. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00418 · Cited by 12 · see citing works

What’s in the pipeline for lower functional gastrointestinal disorders in the next 5 years?

Camilleri, M. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00205.2019 · Cited by 12 · see citing works

New Treatment Options for Chronic Constipation: Mechanisms, Efficacy and Safety

Camilleri, M. (2011) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2011/527583 · Cited by 12 · see citing works

Inhibition of ileal bile acid transporter: An emerging therapeutic strategy for chronic idiopathic constipation

Mosińska, P. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i24.7436 · Cited by 12 · see citing works

New pharmacological treatment options for irritable bowel syndrome with constipation

Nusrat, S., & Miner, P. B. (2015) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2015.1105215 · Cited by 11 · see citing works

The Efficacy and Safety of Elobixibat for the Elderly with Chronic Constipation: A Multicenter Retrospective Cohort Study

Tomie, A., Yoshida, N., Kugai, M., Hirose, R., Dohi, O., Inoue, K., Okuda, K., Motoyoshi, T., Fukumoto, K., Inagaki, Y., et al. (2020) · Gastroenterology Research and Practice · doi:10.1155/2020/9656040 · Cited by 11 · see citing works

Elobixibat improves rectal sensation in patients with chronic constipation aged ≥60 years: a randomised placebo-controlled study

Manabe, N., Umeyama, M., Ishizaki, S., Ota, T., Kuratani, S., Katsumata, R., Fujita, M., Haruma, K., & Camilleri, M. (2023) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2023-001257 · Cited by 11 · see citing works

Efficacy and safety of elobixibat in patients with chronic constipation—A randomized, multicenter, double-blind, placebo-controlled, parallel-group study from India

Agarwal, P., Jha, B. K., Somagoni, J., Srinivas Shenoy, B., Modh, V., Chakilam, S. K., Kumar, V., Vasantrao, M. S., Kalla, M., Kavitha, A., et al. (2025) · Indian Journal of Gastroenterology · doi:10.1007/s12664-024-01719-7 · Cited by 10 · see citing works

Linaclotide, Novel Therapy for the Treatment of Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome

Vázquez‐Roque, M. I., & Bouras, E. P. (2013) · Advances in Therapy · doi:10.1007/s12325-013-0012-9 · Cited by 10 · see citing works

New and Investigational Agents for Irritable Bowel Syndrome

Wadhwa, A., Camilleri, M., & Grover, M. (2015) · Current Gastroenterology Reports · doi:10.1007/s11894-015-0473-x · Cited by 10 · see citing works

The inhibitors of the apical sodium-dependent bile acid transporter (ASBT) as promising drugs

Савельева, Е. Е., Tyutrina, E. S., Nakanishi, T., Tamai, I., & Salmina, A. B. (2020) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20206603185 · Cited by 9 · see citing works

Gastroparesis syndromes: emerging drug targets and potential therapeutic opportunities

Naing, L. Y., Heckroth, M. A., Mathur, P., & Abell, T. L. (2023) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2023.2186222 · Cited by 8 · see citing works

Recent Updates on the Treatment of Constipation

Ryu, H. S., & Choi, S. C. (2015) · Intestinal Research · doi:10.5217/ir.2015.13.4.297 · Cited by 8 · see citing works

Bile Acids and Bowel Function: Do They Play a Role in Constipation-Associated Irritable Bowel Syndrome?

Wald, A. M. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.11.021 · Cited by 7 · see citing works

Strain-specific effect of Limosilactobacillus fermentum with distinct genetic lineages on loperamide-induced constipation in mice: attributing effects to certain genes

Zhao, Y., Zhang, C., Yu, L., Tian, F., Zhao, J., Zhang, H., Chen, W., & Zhai, Q. (2022) · Food & Function · doi:10.1039/d2fo02675a · Cited by 6 · see citing works

Evolving Molecular Targets in the Treatment of Nonmalignant Gastrointestinal Diseases

Katzka, D. A., Loftus, E. V., & Camilleri, M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.77 · Cited by 6 · see citing works

Effects of A3309, an Ileal Bile Acid Transporter Inhibitor, on Colonic Transit and Symptoms in Patients with Functional Constipation

Wong, B. S., Camilleri, M., McKinzie, S., Burton, D. D., Graffner, H., & Zinsmeister, A. R. (2011) · Gastroenterology · doi:10.1016/s0016-5085(11)60595-7 · Cited by 5 · see citing works

Randomised clinical trial: the ileal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation - a double-blind study: Randomised clinical trial: the ASBT/IBAT inhibitor A3309 in constipation

Simrén, M., Bajor, A., Gillberg, P.-G., Rudling, M., & Abrahamsson, H. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04675.x · Cited by 114 · see citing works

nature publishing group ORIGINAL CONTRIBUTIONS 1803 see related editorial on page x A Randomized Placebo-Controlled Phase IIb Trial of A3309, A Bile Acid Transporter Inhibitor,

Constipation, F. C. I., & Graffner, H. (2013)

Den Teufel durch Beelzebub austreiben?

Müller-Lissner, S. A. (2012) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0032-1312906

A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation

Chey, W. D., Camilleri, M., Chang, L., Rikner, L., & Graffner, H. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.162 · Cited by 176 · see citing works